FIELD: medicine, oncology, pharmacy.
SUBSTANCE: invention relates to medicinal agents possessing an antitumor effect. Medicinal agent represents at least one cholinesterase inhibitor taken in the effective dose. Cholinesterase inhibitor is chosen from group comprising physostigmine, pyridostigmine bromide, N-(meta-dimethylcarbamoyloxyphenyl)-trimethylammonium methylsulfate, galanthaminum, 9-amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinoline hydrochloride monohydrate, 9-amino-1,2,3,4-tetrahydroacridine, 2,3-trimethylene-3,4-dihydroquinazoline hydrochloride. This cholinesterase inhibitor is given to a patient by injection route and/or as a tablet. Invention expands assortment of preparations used in treatment of different tumors, provides curing prostate adenoma and adenocarcinoma with high effectiveness and for short time, allows avoidance patients from surgery operation and will allow using cholinesterase inhibitor for prophylactic aims.
EFFECT: valuable medicinal properties of drug.
6 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PROSTATE ADENOMA COMBINED WITH CHRONIC NONBACTERIAL PROSTATITIS | 2014 |
|
RU2568369C1 |
| METHOD FOR TREATMENT OF MALIGNANT TUMOR | 2004 |
|
RU2272647C2 |
| METHOD OF TREATMENT OF ADENOCARCINOMA OF PROSTATE | 2007 |
|
RU2359663C1 |
| METHOD OF TREATING PATIENTS WITH METASTASES IN LYMPH NODES AND OLIGOMETASTATIC DISEASE IN BONES OF SKELETON IN PROSTATE CANCER | 2018 |
|
RU2695348C2 |
| MEANS AND METHOD OF CONDITIONS TREATMENT IMPLYING ANDROGEN ACTION DECREASE IS CONSIDERED TO BE FAVOURABLE, AND METHOD OF ANDROGEN-DEPENDENT TISSUE SENSITIVITY ITENSIFYING USING 9-OXOACRIDINE-10-ACETIC ACID | 2006 |
|
RU2328285C2 |
| METHOD OF TREATING PROSTATE CANCER PERMEATING THROUGH BONE | 2014 |
|
RU2565106C1 |
| METHOD FOR DETERMINING INDICATIONS TO RADICAL PROSTATECTOMY IN PROSTATE CANCER | 2014 |
|
RU2549020C1 |
| METHOD FOR TARGETED BRACHYTHERAPY OF PROSTATE CANCER UNDER HYBRID PSMA-RECEPTOR SCINTIGRAPHY NAVIGATION | 2022 |
|
RU2788859C2 |
| METHOD FOR DETECTING LOCAL PROSTATE CARCINOMA RECURRENCE AFTER RADICAL PROSTATECTOMY | 2003 |
|
RU2224463C1 |
| METHOD FOR TRANSURETHRAL PROSTATIC RESECTION PRECEDING BRACHYTHERAPY OF PROSTATE CANCER | 2011 |
|
RU2519407C2 |
